Saudi COVID-19 clinics help 100,000 people

Saudi Arabia announced 34 more deaths from COVID-19 and 1,482 new cases of the disease on Thursday. (SPA)
Short Url
Updated 14 August 2020

Saudi COVID-19 clinics help 100,000 people

  • The total number of recoveries in the Kingdom has increased to 260,393
  • A total of 3,303 people have succumbed to the virus in the Kingdom so far

JEDDAH: Saudi health clinics set up as testing hubs or treatment centers have helped more than 100,000 people around the Kingdom since the outbreak of the coronavirus pandemic. The Ministry of Health’s Tettamman (rest assured) clinics have offered treatment to 63,529 people, while Taakad (make sure) center services in Al-Ahsa helped 21,030 people.
Al-Ahsa’s Taakad service is available at two locations in Al-Mabraz and Al-Hofuf. The car-stop testing centers’ daily capacity is between 1,200 and 1,500.
In Madinah, Tettamman clinics have offered advice to 18,700 people with COVID-19 symptoms. Three clinics in the city operate daily from 8 a.m. to midnight.
Since it opened, the Taakad drive-through testing center has also offered PCR tests to 5,200 people. Taakad provides COVID-19 testing for those who show no to mild symptoms or believe they have come into contact with an infected individual.
Appointments can be made through the ministry’s Sehaty app. Tettamman clinics offer treatment and advice to those with virus symptoms, such as fever, loss of taste and smell, and breathing difficulties.
Meanwhile, the Kingdom recorded 34 new COVID-19-related deaths on Thursday, raising the total to 3,303.
Saudi Arabia reported 1,482 new cases, meaning 294,519 people have now contracted the disease. There are 30,823 active cases, 1,805 of whom are in critical condition. The ministry also announced that 3,124 more patients had recovered from the illness, bringing the total number of recoveries in the Kingdom to 260,393.
Saudi Arabia has so far conducted 4,071,857 tests, with 70,754 carried out in the past 24 hours.

Major Saudi research center prepares to take part in advanced COVID-19 vaccine trials

Updated 22 September 2020

Major Saudi research center prepares to take part in advanced COVID-19 vaccine trials

  • Ministry of Health and King Abdullah International Medical Research Center have been working with two Chinese drug companies

JEDDAH: King Abdullah International Medical Research Center (KAIMRC) in Saudi Arabia is preparing to take part in advanced trials of one or two COVID-19 vaccines.

About 40 potential vaccines are being tested on humans, nine of which are at the advanced stage of clinical trials to evaluate their safety and effectiveness in protecting people against a virus that has infected more than 31 million people around the world.

The center confirmed its readiness to cooperate with the Kingdom’s Ministry of Health and the Saudi Food and Drug Authority (SFDA) and participate in tests of one or two of the nine vaccines that are in the third phase of clinical trials, during which large-scale testing on humans takes place.

Dr. Naif Al-Harbi, the head of KAIMRC’s drug-development unit, told Al-Ekhbariya TV news channel that it is unprecedented to have nine vaccines in stage three of clinical trials so soon, less than a year, after the emergence of a new virus.

“Approval or disapproval of any drug normally follows the third stage of its clinical trials, which is the last stage,” he added. “Since the pandemic, KAIMRC has been in continuous contact with a number of drug companies in four countries (that are developing vaccines).”

KAIMRC has been working with one Chinese pharmaceutical company in particular to help evaluate and accelerate the development of its vaccine, he said.

“Over the past two months, we have been in contact with Sinovac to scientifically evaluate its product, in term of the tests on animals and a study of the results of stages one and two on humans,” Al-Harbi said.